<h1>Science Navigation Group</h1> <ul> <li><a href="default.asp">Home</a></li> <li><a href="about.asp">About</a></li> <li><a href="careers.asp">Careers and Jobs</a></li> <li><a href="contact.asp">Contact Us</a></li> </ul>
Current Controlled Trials Ltd
 
Profile

Chemistry Central was launched in August 2006 as an independent publishing platform committed to providing immediate free access to peer-reviewed research in all fields of chemistry and chemical sciences. Chemistry Central immediately launched the Chemistry Central Journal, a single journal divided into over 50 subject sections, each edited by a group of senior chemists who together form the Editorial Advisory Board.

All articles published by Chemistry Central are open access, which means they are universally accessible online without charge. Authors retain copyright to their work and grant any third party the right to use the article freely.

The costs of publishing in Chemistry Central journals are covered by article processing charges, typically paid by the author’s institution or funder.

Chemistry Central is a division of BioMed Central Ltd, the largest open access publisher in the world with over 160 journals in its portfolio. As such, BioMed Central’s institutional membership scheme covers Chemistry Central and its journals.

Contacts
Vitek Tracz, group chairman
vitek@sciencenow.com
Matt Cockerill, publisher
matt@biomedcentral.com
Bryan Vickery, deputy publisher
bryan.vickery@chemistrycentral.com
Natasha Robshaw, marketing director
natasha@biomedcentral.com
United Kingdom:
Middlesex House
34-42 Cleveland Street
London W1T 4LB
PHONE: +44 (0)20 7323 0323
FAX: +44 (0)20 7580 1938
EMAIL: info@biomedcentral.com